The Department of Health (Comm) (External organisation)

Wluka, A. (Member)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsMembership of an advisory panel/policy group/ board


Invited member of Post-Market Review committee within the Pharmaceutical Benefits Division of the Department of Health charged to assess the indications for the use of biologics in the treatment of severe chronic plaque psoriasis. Prepared report to influence criteria for the use of these medications, thus changing the access to these medications.
Period13 Feb 201715 Mar 2018
Held atDepartment of Health (Australia), Australia, Australian Capital Territory
Degree of RecognitionNational